Search Results 381-390 of 17710 for SC

  1. Samuel O. Antwi, Ph.D. - Mayo Clinic Faculty Profiles

    PhD - Epidemiology University of South Carolina; MPH - Epidemiology University of Kentucky; BSc (Hons) - Psychology University of Ghana. src="/-/media/kcms/gbs ...

  2. Gastroenterology and Hepatology - Clinical trials

    SC nivolumab in-home treatment may be safe, tolerable and/or effective when compared to in-clinic treatment and may reduce the burden of cancer and improve ...

  3. Irritable bowel syndrome - Doctors and departments - Mayo Clinic

    View all physicians • All Locations · Camilleri, Michael M.D., D.Sc. Minnesota · DiBaise, John K. M.D.. Arizona · Farrugia, Gianrico M.D.. Minnesota · Fox, Jean ...

  4. Vedolizumab Subcutaneous Long-Term Open-Label Extension Study - Mayo Clinic

    The purpose of this study is to obtain long term safety and tolerability data of vedolizumab subcutaneous (vedolizumab SC) in participants with ulcerative ...

  5. Otolaryngology Clinical Trials - Medical Professionals

    SC nivolumab in-home treatment may be safe, tolerable and/or effective when compared to in-clinic treatment and may reduce the burden of cancer and improve ...

  6. Scabies - Symptoms and causes - Mayo Clinic

    A tiny mite called Sarcoptes scabiei causes it. The mite burrows into the skin, causing intense itching. The need to scratch may be stronger at night. Scabies ...

  7. Clinical trials - Oncology (Medical)

    ... SC every 3 weeks in patients with advanced or metastatic sarcoma who are refractory to or intolerant to other available therapies. Also, to evaluate safety ...

  8. Clinical trials - Oncology (Medical)

    ... SC every 3 weeks in patients with advanced or metastatic sarcoma who are refractory to or intolerant to other available therapies. Also, to evaluate safety ...

  9. Clinical trials - Oncology (Medical)

    ... SC every 3 weeks in patients with advanced or metastatic sarcoma who are refractory to or intolerant to other available therapies. Also, to evaluate safety ...

  10. Clinical trials - Lung Cancer Program

    SC nivolumab in-home treatment may be safe, tolerable and/or effective when compared to in-clinic treatment and may reduce the burden of cancer and improve ...